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Editorial
Science  in  the  UK  −  whereto  now?
Humour in Britain is appreciated for its quirkiness and ironic
self-deprecation and can sometimes seem baffling to the outside
world. The outcome of the recent United Kingdom referendum
where a narrow-ish majority voted to leave the European Union
is certainly perplexing to most onlookers and, if its consequences
were not so far-reaching, might be laughed off as an illustration of
such absurd humour. One of the most farcical aspects of the vote
is that no one has any idea what “Brexit” actually means no matter
how often the ignorant slogan “Brexit means Brexit” is repeated.
However, an immediate consequence is that the uncertainties cre-
ated by the vote, and its potential impact on science, continues
to be the subject of widespread, anxious and incredulous debate
amongst scientists in the UK and between their many friends and
collaborators in the world-wide scientific community. Objectively,
it is difficult to discern a single coherent argument that can be made
for Brexit, and there can be little doubt that the human, societal and
financial implications of this needless debacle could be both wide
reaching and damaging.
UK science is highly competitive and EU and UK researchers
have become linked in an extensive collaborative network that has
been of immense benefit to UK (and EU) science, with levels of
inter-country collaborations within the EU (13%) similar to those
of inter-state collaborations within the USA (16%) [1]. Together
with scientists from other EU countries, British scientists com-
prise around 22% of researchers worldwide, way ahead of the USA
(17%) [2]. European researchers are also productive as measured
by publications and author around 34% of the world’s research out-
puts, with the USA trailing at 23% [1]. Between 2005 and 2014,
UK researcher output rose from 70,201 to 87,948, second only to
Germany (73,573–91,631) and way ahead of next-placed France
(52,476–65,086). Indeed, for publications in biological and medi-
cal sciences, British authors are the most prolific by far (Fig. 1). UK
institutions have been awarded by far the most research grants
by the European Research Council [3], which funds individual
projects solely on the basis of their scientific excellence and so
helps researchers bypass what is sometimes perceived as a less
objective distribution of monies from national research councils.
Between 2007 and 2015, the UK accounted for 639/3056 grants,
with next-placed Germany obtaining 440. The UK has been simi-
larly successful with the EU’s Horizon 2020 programme, with nearly
12% of the applications received under the first 100 calls accounting
for 15% of the available funding [4]. The Royal Society reckons from
data released by the UK Office of National Statistics that between
2007 and 2013 the UK received a net amount of D 2.9 billion in direct
EU funding for research, development and innovation activities
[5].
EU funding has become essential to British science, since it is
augmenting UK-based research at a time when British government
funding is decreasing. Undoubtedly there are many ways of pre-
senting the available financial data, but a straightforward reading
of the likely unbiased UNESCO Science report reveals that the ratio
of UK gross domestic expenditure on research and development
(GRED) to GDP declined from 1.75 in 2009–1.63 in 2013, at a time
when the average ratio for all 28 EU countries rose from 1.94 to 2.02
[1]. The UK government’s own figures show that whilst in 2014 it
spent £11.0 billion on science, engineering and technology, a nom-
inal increase of 0.4% compared with 2013, once inflation is taken
into account this represented a 1.0% decrease. Furthermore, the
contribution of the UK Research Councils, which amounted to 31%
of all expenditure in this area, decreased by 3% in current prices
compared with 2013 [6].
The financial argument for the UK remaining within the EU is
clearly overwhelming, but is but one aspect of the importance of
membership of the EU for British and European science. The contin-
ued free movement of people is similarly significant and is vital for
creating global network of contacts, helps stimulate innovation and
the inherent exposure to different cultures and viewpoints helps
make this a better world. The English-speaking UK with its close
links to the USA is a very attractive destination for experienced aca-
demics, students and post-doctoral workers alike, who contribute
not just their talents and enrich society with their cultural diver-
sity but also make a significant economic and financial contribution
to the UK in general and universities in particular. It is particu-
larly ironical (more British humour?) that the UK government sees
tougher regulation on universities as an appropriate way  of reduc-
ing net immigration and argues that universities should develop
sustainable funding models that are not so dependent on interna-
tional students [7]. How ingenious then to threaten the potential for
EU funding, which goes mainly to scientists working at universities
and research institutions, by withdrawing from the EU. Further-
more, most students return to their home countries and carry
back with them the impressions, values and principles they have
acquired in the UK and become part of the international collabo-
rative network that has become the hallmark of modern science.
Of course, the British pharmaceutical and biotechnology indus-
tries and many small and medium enterprises innovating scientific
instrumentation, medical devices and diagnostic kits also make an
essential contribution to overall scientific output and advances and
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Fig. 1. Scientific publications authored by scientists located in the four largest EU member states.
benefit from trans-national funding and the free movement of peo-
ple and services.
An authoritative and comprehensive examination of the Euro-
pean publics’ attitude to science and technology suggest that
most people understand the fundamental importance of these
issues [8]. The increasing importance of collaborative research is
acknowledged by 74% of respondents, with only 5% disagreeing.
Interestingly the UK was second from bottom amongst all EU coun-
tries, although a healthy 64% agreed with that statement and only
9% disagreed. Most people also believe that collaborative research
is in the national (66% vs 10%) and society’s (69% vs 9%) interest and
that it makes science more creative and efficient (62% vs 9%). Again
it is notable that UK respondents are not as convinced (51% vs 14%).
The public also understand that it is normal for EU researchers to
move from one member state to another to further their career (59%
agree, 11% disagree), but it is again noticeable that the UK public are
less likely to agree with this requisite: only 46% agree, whereas 18%
disagree). Finally, 72% of Europeans believe, compared to 7% that
do not, that it is important to create European research centres that
allow researchers from all EU countries to collaborate at one physi-
cal location. Again the UK response is somewhat less positive, with
only 61% of that opinion, compared to 11% that disagree.
One of the most notable features of the referendum campaign
in the UK was the reliably ill-informed and coarse standard of dis-
course, which gave rise to many dispiriting comments from both
sides of the divide. The true consequences of leaving the EU were
rarely made clear in a manner that could be objectively deliberated
by the electorate; instead arguments were generally characterised
by emotion, fabrication and misrepresentation of facts. For scien-
tists, one of the most foolish assertions surely was the declaration
by the then justice secretary Michael Gove, a graduate of the Uni-
versity of Oxford, that “people in this country have had enough
of experts”. Whilst this comment appeared to be directed specifi-
cally at economists, it nevertheless represents a shocking attitude
by a supposedly educated member of the establishment. However,
there is a wider context to consider, since the media regularly
broadcasts scientific and medical discoveries, and scientists appear
as experts to explain one finding or other, frequently offering differ-
ent opinions. Hence comments such as the one by Mr  Gove should
make us think and re-evaluate our own  role as scientists and how
the wider community perceives our role and expertise.
The usual definition of an expert is someone who is knowl-
edgeable about or skilful in a particular area. An expert’s role
with regards to communication is to use that expertise to provide
impartial, comprehensive and relevant research- and fact-based
evidence. To be credible, the expert must convey sincerity and
integrity and if the communication is done competently, sensitively
and appropriately, that evidence should provide the information a
target audience requires to act, or in the case of the UK referendum,
vote rationally. Ultimately, an expert’s value depends on whether
the public can trust that expert’s testimony. Trust is precious and
must be earned, and there have been several reasons why some
people might be mistrustful of scientists. One of the most egre-
gious instances of how dubious science affects public wellbeing is
provided by the controversy surrounding the link between of the
measles mumps  and rubella vaccine and autism [9]. Despite numer-
ous studies refuting any such link [10–14] and despite judgements
by the US federal vaccine injury compensation court upheld on
appeal [15], many members of the public remain unconvinced that
there is no connection between the two [16–18]. Other examples
include serious incidents biosafety incidents, which have occurred
in laboratories operated by the Centers for Disease Control and
Prevention (CDC) [19,20] and there are frequent reports of safety
violations and accidents at research facilities around the world. In
the UK a Guardian newspaper investigation uncovered over 100
accidents or near-misses at the high-security labs that handle the
most dangerous viruses and bacteria [21]. Such events must be han-
dled in a transparent, candid and respectful manner if they are not
to damage people’s trust in science and scientists.
In any event, the public’s opinion of science and scientists is
not straightforward. Any survey needs to be taken with a pinch of
salt these days, but the 2010 European Commission’s report on sci-
ence and technology paints a broadly positive picture of the general
publics’ perception, albeit with a few worrying tendencies. There is
a broad awareness of science, with 79% of Europeans either very or
moderately interested in new scientific discoveries and 61% feeling
either well or moderately well informed about them [8]. They are
also optimistic about the effects of science and technology, with 75%
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expecting science and technology to provide more opportunities
for future generations, although 57% feel that scientists should put
more effort into informing the public about these changes. Encour-
agingly, a majority (55%) of Europeans sees the need for a public
dialogue when decisions about new developments in science and
technology are made [22]). However, 62% feel that science and tech-
nology can sometimes damage people’s moral sense and that 53%
agree with the statement that, because of their knowledge, scien-
tists “have a power that makes them dangerous”. The jury remain
out on how all of this affects the public’s trust: 58% of Europeans
think that the increasing dependence on funding from industry
means that scientists can no longer be trusted to tell the truth about
controversial scientific and technological issues. Interestingly, 70%
of respondents in the scientific powerhouse Germany 70% agreed
with that statement. Perhaps there is a link to the perception of
50% of respondents who believe that private funding of scientific
and technological research limits the ability to understand things
fully. Conversely, in the UK scientists are a trusted profession, with
the two most recent Ipsos Mori veracity indices suggesting that 83%
(2014) [23] or 79% (2015) [24] of the UK population trusts scientists
to tell the truth.
So what are we to do? Most scientists (85%) see the public’s
lack of knowledge about science as a major problem and 76% also
complain about the media’s lack of distinction between sound sci-
ence and unscientific twaddle [25]. I strongly believe that one of
the lessons of the Brexit debacle is that scientists must become far
more proactive in their involvement with and influence of poli-
tics. We  must accept that we need to engage in an active role with
the general public and demonstrate the significance and benefits
of our research, perhaps by joining political parties and shap-
ing policies right from the start. Historically, scientists believe in
transparent, respectful and rational debate that tolerates and even
encourages different opinions. We  are used to developing hypothe-
ses, searching for factual evidence and modifying our hypotheses
if our experimental facts change, all in a search for truth. Few sci-
entists, and certainly not those in academic posts, are motivated
by avarice, many, especially in less democratic countries, continue
to be examples of moral courage and most have a sincere social
conscience, sense of solidarity and are colour-blind. If we  really are
entering a post-truth world that seems to be characterised by nar-
cicissm, material greed, lack of moral courage and unwillingness
or inability to stand up for principles, I would argue that scien-
tists should act as beacons for pluralism, social justice, tolerance
and reflective thought. Of course, rational debate and facts may
not be sufficient to convince an audience that has an emotional
attachment to its views. Although scientists know that a question-
ing attitude is preferable to a dogmatic approach, most people are
confused by scientific debate where several, sometimes contradic-
tory, opinions are discussed and where there may  be more than one
correct answer. We  need to acknowledge this; but we also need to
inject some passion into our arguments, especially as there is plenty
to be passionate about: investment in science is a positive thing and
is essential for prosperity, it benefits society, provides employment,
improves health, brings people and cultures together, is generally
a force for good and, above all, science is exciting.
With regards to Brexit, for all its faults, the EU has nourished
these values, especially with its drive towards funding excellence,
encouraging the exchange of people and focussing on topics that
individual nation states tended to neglect. This should be an incen-
tive for us to “take back control” and not let politicians, journalists
and other special interest groups destroy our precious network
of friends, collaborators, institutions and openness we have built
up over the past 40 years. There are many issues that must be
tackled and we must not be afraid to discuss these openly and
with the greatest possible transparency. These include the seri-
ous problems associated with inefficiency, lack of reproducibility
and mistaken research priorities of biomedical research [26–31],
laboratory errors [32,33] and other issues highlighted in numer-
ous publications [34–40]. We  might also want to consider speaking
up against the challenges associated with the politicians’ love for
ludicrous quality metrics, the publish-or-perish culture that fos-
ters the publication of poor research, the associated inadequacy
of the peer review system and the increasing focus on translation
research at the cost of creative exploration. None of these issues
can be addressed unless we  are willing to engage with the many
interests that have driven these developments, some of which
are self-inflicted and self-perpetuating. But involve ourselves we
must, otherwise we cannot complain if others make vital decisions
against our judgements and interests that might jeopardise our
futures.
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